Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation

Abderrahim Nemmar,1 Sulayma Albarwani,2 Sumaya Beegam,1 Priya Yuvaraju,1 Javed Yasin,3 Samir Attoub,4 Badreldin H Ali5 1Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 2Department of Physiology, College of Medicine a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nemmar A, Albarwani S, Beegam S, Yuvaraju P, Yasin J, Attoub S, Ali BH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/38061be39d144750b403829ab0d4d162
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:38061be39d144750b403829ab0d4d162
record_format dspace
spelling oai:doaj.org-article:38061be39d144750b403829ab0d4d1622021-12-02T03:54:12ZAmorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation1178-2013https://doaj.org/article/38061be39d144750b403829ab0d4d1622014-06-01T00:00:00Zhttp://www.dovepress.com/amorphous-silica-nanoparticles-impair-vascular-homeostasis-and-induce--a17082https://doaj.org/toc/1178-2013 Abderrahim Nemmar,1 Sulayma Albarwani,2 Sumaya Beegam,1 Priya Yuvaraju,1 Javed Yasin,3 Samir Attoub,4 Badreldin H Ali5 1Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 2Department of Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khod, Sultanate of Oman; 3Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 4Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 5Department of Pharmacology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khod, Sultanate of Oman Abstract: Amorphous silica nanoparticles (SiNPs) are being used in biomedical, pharmaceutical, and many other industrial applications entailing human exposure. However, their potential vascular and systemic pathophysiologic effects are not fully understood. Here, we investigated the acute (24 hours) systemic toxicity of intraperitoneally administered 50 nm and 500 nm SiNPs in mice (0.5 mg/kg). Both sizes of SiNPs induced a platelet proaggregatory effect in pial venules and increased plasma concentration of plasminogen activator inhibitor-1. Elevated plasma levels of von Willebrand factor and fibrinogen and a decrease in the number of circulating platelets were only seen following the administration of 50 nm SiNPs. The direct addition of SiNPs to untreated mouse blood significantly induced in vitro platelet aggregation in a dose-dependent fashion, and these effects were more pronounced with 50 nm SiNPs. Both sizes of SiNPs increased lactate dehydrogenase activity and interleukin 1β concentration. However, tumor necrosis factor α concentration was only increased after the administration of 50 nm SiNPs. Nevertheless, plasma markers of oxidative stress, including 8-isoprostane, thiobarbituric acid reactive substances, catalase, and glutathione S-transferase, were not affected by SiNPs. The in vitro exposure of human umbilical vein endothelial cells to SiNPs showed a reduced cellular viability, and more potency was seen with 50 nm SiNPs. Both sizes of SiNPs caused a decrease in endothelium-dependent relaxation of isolated small mesenteric arteries. We conclude that amorphous SiNPs cause systemic inflammation and coagulation events, and alter vascular reactivity. Overall, the effects observed with 50 nm SiNPs were more pronounced than those with 500 nm SiNPs. These findings provide new insight into the deleterious effect of amorphous SiNPs on vascular homeostasis. Keywords: amorphous silica nanoparticles, thrombosis, toxicity, systemic inflammationNemmar AAlbarwani SBeegam SYuvaraju PYasin JAttoub SAli BHDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 2779-2789 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Nemmar A
Albarwani S
Beegam S
Yuvaraju P
Yasin J
Attoub S
Ali BH
Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
description Abderrahim Nemmar,1 Sulayma Albarwani,2 Sumaya Beegam,1 Priya Yuvaraju,1 Javed Yasin,3 Samir Attoub,4 Badreldin H Ali5 1Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 2Department of Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khod, Sultanate of Oman; 3Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 4Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 5Department of Pharmacology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khod, Sultanate of Oman Abstract: Amorphous silica nanoparticles (SiNPs) are being used in biomedical, pharmaceutical, and many other industrial applications entailing human exposure. However, their potential vascular and systemic pathophysiologic effects are not fully understood. Here, we investigated the acute (24 hours) systemic toxicity of intraperitoneally administered 50 nm and 500 nm SiNPs in mice (0.5 mg/kg). Both sizes of SiNPs induced a platelet proaggregatory effect in pial venules and increased plasma concentration of plasminogen activator inhibitor-1. Elevated plasma levels of von Willebrand factor and fibrinogen and a decrease in the number of circulating platelets were only seen following the administration of 50 nm SiNPs. The direct addition of SiNPs to untreated mouse blood significantly induced in vitro platelet aggregation in a dose-dependent fashion, and these effects were more pronounced with 50 nm SiNPs. Both sizes of SiNPs increased lactate dehydrogenase activity and interleukin 1β concentration. However, tumor necrosis factor α concentration was only increased after the administration of 50 nm SiNPs. Nevertheless, plasma markers of oxidative stress, including 8-isoprostane, thiobarbituric acid reactive substances, catalase, and glutathione S-transferase, were not affected by SiNPs. The in vitro exposure of human umbilical vein endothelial cells to SiNPs showed a reduced cellular viability, and more potency was seen with 50 nm SiNPs. Both sizes of SiNPs caused a decrease in endothelium-dependent relaxation of isolated small mesenteric arteries. We conclude that amorphous SiNPs cause systemic inflammation and coagulation events, and alter vascular reactivity. Overall, the effects observed with 50 nm SiNPs were more pronounced than those with 500 nm SiNPs. These findings provide new insight into the deleterious effect of amorphous SiNPs on vascular homeostasis. Keywords: amorphous silica nanoparticles, thrombosis, toxicity, systemic inflammation
format article
author Nemmar A
Albarwani S
Beegam S
Yuvaraju P
Yasin J
Attoub S
Ali BH
author_facet Nemmar A
Albarwani S
Beegam S
Yuvaraju P
Yasin J
Attoub S
Ali BH
author_sort Nemmar A
title Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
title_short Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
title_full Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
title_fullStr Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
title_full_unstemmed Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
title_sort amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/38061be39d144750b403829ab0d4d162
work_keys_str_mv AT nemmara amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
AT albarwanis amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
AT beegams amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
AT yuvarajup amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
AT yasinj amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
AT attoubs amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
AT alibh amorphoussilicananoparticlesimpairvascularhomeostasisandinducesystemicinflammation
_version_ 1718401541277220864